Arcutis Biotherapeutics (NASDAQ:ARQT) Issues Quarterly Earnings Results, Beats Expectations By $0.09 EPS
Arcutis Biotherapeutics (NASDAQ:ARQT – Get Free Report) announced its earnings results on Wednesday. The company reported ($0.33) EPS for the quarter, beating analysts’ consensus estimates of ($0.42) by $0.09, Zacks reports. The business had revenue of $44.76 million during the quarter, compared to analysts’ expectations of $38.05 million. Arcutis Biotherapeutics had a negative net margin […]
More Stories
Calamos S&P 500 Structured Alt Protection ETF – September (NYSEARCA:CPST) Now Covered by StockNews.com
StockNews.com started coverage on shares of Calamos S&P 500 Structured Alt Protection ETF – September (NYSEARCA:CPST – Free Report) in...
Qualys (NASDAQ:QLYS) Updates Q4 Earnings Guidance
Qualys (NASDAQ:QLYS – Get Free Report) issued an update on its fourth quarter earnings guidance on Tuesday morning. The company...
Discover Financial Services (NYSE:DFS) Rating Lowered to “Hold” at StockNews.com
StockNews.com lowered shares of Discover Financial Services (NYSE:DFS) from a buy rating to a hold rating in a report issued...
WisdomTree Global ex U.S. Quality Dividend Growth Fund (NYSEARCA:DNL) Trading 2% Higher – Here’s Why
WisdomTree Global ex U.S. Quality Dividend Growth Fund (NYSEARCA:DNL – Get Free Report) shares rose 2% on Thursday . The...
First Trust NASDAQ 100 Ex-Technology Sector Index Fund (NASDAQ:QQXT) Trading 0.6% Higher – What’s Next?
Shares of First Trust NASDAQ 100 Ex-Technology Sector Index Fund (NASDAQ:QQXT – Get Free Report) rose 0.6% on Thursday ....
First Trust United Kingdom AlphaDEX Fund (NASDAQ:FKU) Trading 0.8% Higher – Time to Buy?
First Trust United Kingdom AlphaDEX Fund (NASDAQ:FKU – Get Free Report)’s stock price rose 0.8% on Thursday . The company...